Physical Exercise Attenuates MPTP-Induced Deficits in Mice

Two experiments were performed to investigate the effects of physical exercise upon the hypokinesia induced by two different types of MPTP administration to C57/BL6 mice. In the first, mice were administered either the standard MPTP dose (2 × 20 or 2 × 40 mg/kg, 24-h interval) or vehicle (saline, 5 ml/kg); and over the following 3 weeks were given daily 30-min period of wheel running exercise over five consecutive days/week or placed in a cage in close proximity to the running wheels. Spontaneous motor activity testing in motor activity test chambers indicated that exercise attenuated the hypokinesic effects of both doses of MPTP upon spontaneous activity or subthreshold l-Dopa-induced activity. In the second experiment, mice were either given wheel running activity on four consecutive days (30-min period) or placed in a cage nearby and on the fifth day, following motor activity testing over 60 min, injected with either MPTP (1 × 40 mg/kg) or vehicle. An identical procedure was maintained over the following 4 weeks with the exception that neither MPTP nor vehicle was injected after the fifth week. The animals were left alone (without either exercise or MPTP) and tested after 2- and 4-week intervals. Weekly exercise blocked, almost completely, the progressive development of severe hypokinesia in the MPTP mice and partially restored normal levels of activity after administration of subthreshold l-Dopa, despite the total absence of exercise following the fifth week. In both experiments, MPTP-induced loss of dopamine was attenuated by the respective regime of physical exercise with dopamine integrity more effectively preserved in the first experiment. The present findings are discussed in the context of physical exercise influences upon general plasticity and neuroreparative propensities as well as those specific for the nigrostriatal pathway.

[1]  D. Bilowit Establishing physical objectives in the rehabilitation of patients with Parkinson's disease; gymnasium activities. , 1956, The Physical therapy review.

[2]  R. Kirk Experimental Design: Procedures for the Behavioral Sciences , 1970 .

[3]  J. Langston MPTP neurotoxicity: an overview and characterization of phases of toxicity. , 1985, Life sciences.

[4]  S. Palmer,et al.  Exercise therapy for Parkinson's disease. , 1986, Archives of physical medicine and rehabilitation.

[5]  P. Sonsalla,et al.  The influence of dose and dosing interval on MPTP-induced dopaminergic neurotoxicity in mice. , 1986, European journal of pharmacology.

[6]  A. Hurwitz,et al.  The Benefit of a Home Exercise Regimen for Ambulatory Parkinson's Disease Patients , 1989, The Journal of neuroscience nursing : journal of the American Association of Neuroscience Nurses.

[7]  P. Sonsalla,et al.  Some features of the nigrostriatal dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the mouse. , 1989, Molecular and chemical neuropathology.

[8]  T. Archer,et al.  MPTP-induced hypoactivity in mice: reversal by L-dopa. , 1990, Pharmacology & toxicology.

[9]  T. Archer,et al.  Chronic neurochemical and behavioral changes in MPTP-lesioned C57BL/6 mice: a model for Parkinson's disease , 1990, Brain Research.

[10]  T. Lewander,et al.  (S)-UH-301 antagonizes (R)-8-OH-DPAT-induced cardiovascular effects in the rat. , 1991, European journal of pharmacology.

[11]  T. Archer,et al.  MPTP-induced behavioural and biochemical deficits: A parametric analysis , 1994, Journal of neural transmission. Parkinson's disease and dementia section.

[12]  T. Lewander,et al.  Derivatives of cis-2-amino-8-hydroxy-1-methyltetralin: mixed 5-HT1A-receptor agonists and dopamine D2-receptor antagonists. , 1995, Journal of medicinal chemistry.

[13]  R. Burke,et al.  Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. , 1995, Neurodegeneration : a journal for neurodegenerative disorders, neuroprotection, and neuroregeneration.

[14]  P. Pévet,et al.  Daily hypocaloric feeding entrains circadian rhythms of wheel-running and body temperature in rats kept in constant darkness , 1996, Neuroscience Letters.

[15]  R. Passingham,et al.  Self-initiated versus externally triggered movements. I. An investigation using measurement of regional cerebral blood flow with PET and movement-related potentials in normal and Parkinson's disease subjects. , 1996, Brain : a journal of neurology.

[16]  M. Delong,et al.  Functional and pathophysiological models of the basal ganglia , 1996, Current Opinion in Neurobiology.

[17]  D. German,et al.  The neurotoxin MPTP causes degeneration of specific nucleus A8, A9 and A10 dopaminergic neurons in the mouse. , 1996, Neurodegeneration : a journal for neurodegenerative disorders, neuroprotection, and neuroregeneration.

[18]  Cm Sherwin,et al.  The use and perceived importance of three resources which provide caged laboratory mice the opportunity for extended locomotion , 1998 .

[19]  C. Sherwin,et al.  Voluntary wheel running: a review and novel interpretation , 1998, Animal Behaviour.

[20]  T. Garland,et al.  Effects of voluntary activity and genetic selection on aerobic capacity in house mice (Mus domesticus). , 1998, Journal of applied physiology.

[21]  T. Garland,et al.  Artificial Selection for Increased Wheel-Running Behavior in House Mice , 1998, Behavior genetics.

[22]  T. Chase,et al.  Tolerance to a suprathreshold dose of L-Dopa in MPTP mice: effects of glutamate antagonists , 1999, Journal of Neural Transmission.

[23]  H J Helminen,et al.  Effect of access to a running wheel on behavior of C57BL/6J mice. , 1999, Laboratory animal science.

[24]  M. Byrne,et al.  Pairings of a distinctive chamber with the aftereffect of wheel running produce conditioned place preference , 2000, Appetite.

[25]  R. Passingham,et al.  Self-initiated versus externally triggered movements. II. The effect of movement predictability on regional cerebral blood flow. , 2000, Brain : a journal of neurology.

[26]  F. Chollet,et al.  Cortical motor reorganization in akinetic patients with Parkinson's disease: a functional MRI study. , 2000, Brain : a journal of neurology.

[27]  P. Thorén,et al.  Running and cocaine both upregulate dynorphin mRNA in medial caudate putamen , 2000, The European journal of neuroscience.

[28]  I. Miyai,et al.  Treadmill training with body weight support: its effect on Parkinson's disease. , 2000, Archives of physical medicine and rehabilitation.

[29]  M. Carulla,et al.  Entrainment of the rat motor activity rhythm effects of the light–dark cycle and physical exercise , 2000, Physiology & Behavior.

[30]  M. Zigmond,et al.  Forced Limb-Use Effects on the Behavioral and Neurochemical Effects of 6-Hydroxydopamine , 2001, The Journal of Neuroscience.

[31]  S. Dunnett,et al.  The influence of environment and experience on neural grafts , 2001, Nature Reviews Neuroscience.

[32]  I. Izquierdo,et al.  Neonatal iron potentiates adult MPTP-induced neurodegenerative and functional deficits. , 2001, Parkinsonism & related disorders.

[33]  J. Lindsay,et al.  Physical activity and risk of cognitive impairment and dementia in elderly persons. , 2001, Archives of neurology.

[34]  S. Totterdell,et al.  Mouse model of Parkinsonism: a comparison between subacute MPTP and chronic MPTP/probenecid treatment , 2001, Neuroscience.

[35]  G. Miller,et al.  Detection of Behavioral Impairments Correlated to Neurochemical Deficits in Mice Treated with Moderate Doses of 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine , 2002, Experimental Neurology.

[36]  C. Cotman,et al.  Exercise: a behavioral intervention to enhance brain health and plasticity , 2002, Trends in Neurosciences.

[37]  Roland R Roy,et al.  Voluntary exercise induces a BDNF-mediated mechanism that promotes neuroplasticity. , 2002, Journal of neurophysiology.

[38]  T. Archer,et al.  An antihypokinesic action of α2-adrenoceptors upon MPTP-induced behaviour deficits in mice , 2003, Journal of Neural Transmission.

[39]  M. Zigmond,et al.  Can the brain be protected through exercise? Lessons from an animal model of parkinsonism☆ , 2003, Experimental Neurology.

[40]  G. Miller,et al.  Exercise induces behavioral recovery and attenuates neurochemical deficits in rodent models of Parkinson's disease , 2003, Neuroscience.

[41]  J. Mehrholz,et al.  Immediate effects of speed-dependent treadmill training on gait parameters in early Parkinson's disease. , 2003, Archives of physical medicine and rehabilitation.

[42]  T. Archer,et al.  Effect of postnatal iron administration on MPTP-induced behavioral deficits and neurotoxicity: behavioral enhancement by L-Dopa-MK-801 co-administration , 2003, Behavioural Brain Research.

[43]  M. Zigmond,et al.  Neuroprotective effects of prior limb use in 6‐hydroxydopamine‐treated rats: possible role of GDNF , 2003, Journal of neurochemistry.

[44]  S. Dunnett,et al.  Motor training effects on recovery of function after striatal lesions and striatal grafts , 2003, Experimental Neurology.

[45]  T. Lewander,et al.  Central noradrenaline depletion antagonizes aspects ofd-amphetamine-induced hyperactivity in the rat , 2004, Psychopharmacology.

[46]  E. Borrelli,et al.  Wheel running use in dopamine D2L receptor knockout mice , 2004, Neuroscience Letters.

[47]  J. Schneider,et al.  Attention and executive function deficits in chronic low‐dose MPTP‐treated non‐human primates , 2004, The European journal of neuroscience.

[48]  Y. Lau Progressive Neurodegeneration in the Chronic MPTP/Probenecid Model of Parkinson’s Disease , 2004 .

[49]  A. Nissinen,et al.  Physical activity in relation to cognitive decline in elderly men , 2004, Neurology.

[50]  B. Fisher,et al.  Exercise‐induced behavioral recovery and neuroplasticity in the 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine‐lesioned mouse basal ganglia , 2004, Journal of neuroscience research.

[51]  S. Kleeberger,et al.  Genetic influence on daily wheel running activity level. , 2004, Physiological genomics.

[52]  Leonie de Visser,et al.  Automated home cage observations as a tool to measure the effects of wheel running on cage floor locomotion , 2005, Behavioural Brain Research.

[53]  L. Panton,et al.  The effects of loading and unloading treadmill walking on balance, gait, fall risk, and daily function in Parkinsonism. , 2005, NeuroRehabilitation.

[54]  M. Trivedi,et al.  Exercise treatment for depression: efficacy and dose response. , 2005, American journal of preventive medicine.

[55]  S. Kleeberger,et al.  Influence of genetic background on daily running-wheel activity differs with aging. , 2005, Physiological genomics.

[56]  T. Archer,et al.  Influence of noradrenaline denervation on MPTP-induced deficits in mice , 2006, Journal of Neural Transmission.

[57]  D. Garris,et al.  Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson’s disease , 2006, Neuroscience.

[58]  L. Ramig,et al.  The science and practice of LSVT/LOUD: neural plasticity-principled approach to treating individuals with Parkinson disease and other neurological disorders. , 2006, Seminars in speech and language.

[59]  T. Archer,et al.  Postnatal iron overload destroys NA-DA functional interactions , 2007, Journal of Neural Transmission.

[60]  T. Archer,et al.  Synergistic interactions between NMDA-antagonists and L-Dopa on activity in MPTP-treated mice , 2006, Journal of Neural Transmission / General Section JNT.

[61]  M. Kas,et al.  Effects of genetic background and environmental novelty on wheel running as a rewarding behaviour in mice , 2007, Behavioural Brain Research.

[62]  T. Archer,et al.  Functional Consequences of Iron Overload in Catecholaminergic Interactions: the Youdim Factor , 2007, Neurochemical Research.

[63]  S. O'dell,et al.  Running wheel exercise enhances recovery from nigrostriatal dopamine injury without inducing neuroprotection , 2007, Neuroscience.

[64]  D. Woitalla,et al.  Exercise improves efficacy of levodopa in patients with Parkinson's disease , 2007, Movement disorders : official journal of the Movement Disorder Society.

[65]  John P. Walsh,et al.  Effects of Treadmill Exercise on Dopaminergic Transmission in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Lesioned Mouse Model of Basal Ganglia Injury , 2007, The Journal of Neuroscience.

[66]  L. Stehno-Bittel,et al.  Endurance exercise promotes cardiorespiratory rehabilitation without neurorestoration in the chronic mouse model of Parkinsonism with severe neurodegeneration , 2007, Neuroscience.

[67]  Hee-Hyuk Lee,et al.  Treadmill exercise suppresses nigrostriatal dopaminergic neuronal loss in 6-hydroxydopamine-induced Parkinson's rats , 2007, Neuroscience Letters.

[68]  Melissa Scott-Pandorf,et al.  A chronic mouse model of Parkinson's disease has a reduced gait pattern certainty , 2007, Neuroscience Letters.

[69]  Max J Kurz,et al.  Restorative effect of endurance exercise on behavioral deficits in the chronic mouse model of Parkinson's disease with severe neurodegeneration , 2009, BMC Neuroscience.

[70]  B. Bloem,et al.  Nordic walking improves mobility in Parkinson's disease , 2008, Movement disorders : official journal of the Movement Disorder Society.

[71]  C. Pantev,et al.  Frequency-specific modulation of population-level frequency tuning in human auditory cortex , 2009, BMC Neuroscience.

[72]  Adrian H. Taylor,et al.  The effectiveness of exercise interventions for people with Parkinson's disease: A systematic review and meta‐analysis , 2008, Movement disorders : official journal of the Movement Disorder Society.

[73]  J. Rocha,et al.  Influence of chronic exercise on reserpine-induced oxidative stress in rats: Behavioral and antioxidant evaluations , 2008, Pharmacology Biochemistry and Behavior.

[74]  M. Fleshner,et al.  Neuroplasticity of Dopamine Circuits After Exercise: Implications for Central Fatigue , 2008, NeuroMolecular Medicine.

[75]  R. Wood,et al.  Memory, mood, dopamine, and serotonin in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse model of basal ganglia injury , 2008, Neurobiology of Disease.

[76]  T. Schallert,et al.  Limb use and complex ultrasonic vocalization in a rat model of Parkinson's disease: deficit-targeted training. , 2008, Parkinsonism & related disorders.

[77]  Ali Montazeri,et al.  Exercise therapy, quality of life, and activities of daily living in patients with Parkinson disease: a small scale quasi-randomised trial , 2009, Trials.

[78]  Ji-Hyuk Park,et al.  Effects of endurance exercise on ventral tegmental area neurons in the chronic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and probenecid-treated mice , 2009, Neuroscience Letters.

[79]  C. Coimbra,et al.  Performance-enhancing and thermoregulatory effects of intracerebroventricular dopamine in running rats , 2009, Pharmacology Biochemistry and Behavior.

[80]  Jay L Alberts,et al.  Forced, Not Voluntary, Exercise Improves Motor Function in Parkinson's Disease Patients , 2009, Neurorehabilitation and neural repair.

[81]  Pierpaolo Pani,et al.  A network of reverberating neuronal populations encodes motor decision in macaque premotor cortex , 2009, BMC Neuroscience.

[82]  U. Çamsarı,et al.  Effect of acute and chronic exercise on oxidant–antioxidant equilibrium in rat hippocampus, prefrontal cortex and striatum , 2009, Neuroscience Letters.

[83]  T. Garland,et al.  Endurance capacity of mice selectively bred for high voluntary wheel running , 2009, Journal of Experimental Biology.